BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31061163)

  • 21. High-Throughput Screening Assays for Dengue Antiviral Drug Development.
    Jabanathan SG; Xuan LZ; Ramanathan B
    Methods Mol Biol; 2021; 2296():279-302. PubMed ID: 33977455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a flavivirus RNA-dependent RNA polymerase assay to investigate the antiviral activity of selected compounds.
    Bartholomeusz A; Tomlinson E; Wright PJ; Birch C; Locarnini S; Weigold H; Marcuccio S; Holan G
    Antiviral Res; 1994 Aug; 24(4):341-50. PubMed ID: 7993077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
    De Burghgraeve T; Kaptein SJ; Ayala-Nunez NV; Mondotte JA; Pastorino B; Printsevskaya SS; de Lamballerie X; Jacobs M; Preobrazhenskaya M; Gamarnik AV; Smit JM; Neyts J
    PLoS One; 2012; 7(5):e37244. PubMed ID: 22624001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
    De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
    Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology and disease burden of children hospitalized for viral infections within the family Flaviviridae in China: A national cross-sectional study.
    Wang R; Wang X; Zhang L; Feng G; Liu M; Zeng Y; Xie Z
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010562. PubMed ID: 35788743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
    Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
    Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel antiviral activity of baicalein against dengue virus.
    Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
    BMC Complement Altern Med; 2012 Nov; 12():214. PubMed ID: 23140177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten years of dengue drug discovery: progress and prospects.
    Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
    Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.
    Anwar A; Hosoya T; Leong KM; Onogi H; Okuno Y; Hiramatsu T; Koyama H; Suzuki M; Hagiwara M; Garcia-Blanco MA
    PLoS One; 2011; 6(8):e23246. PubMed ID: 21858043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals.
    Pu S; Schor S; Karim M; Saul S; Robinson M; Kumar S; Prugar LI; Dorosky DE; Brannan J; Dye JM; Einav S
    Antiviral Res; 2020 Dec; 184():104966. PubMed ID: 33137362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a Direct-Acting Antiviral Agent Targeting RNA Helicase via a Graphene Oxide Nanobiosensor.
    Kim J; Park SJ; Park J; Shin H; Jang YS; Woo JS; Min DH
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25715-25726. PubMed ID: 34036784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
    Franco EJ; Pires de Mello CP; Brown AN
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
    Qiu L; Patterson SE; Bonnac LF; Geraghty RJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006421. PubMed ID: 29672522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.
    Smith JL; Stein DA; Shum D; Fischer MA; Radu C; Bhinder B; Djaballah H; Nelson JA; Früh K; Hirsch AJ
    J Virol; 2014 May; 88(10):5533-42. PubMed ID: 24599995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
    Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordant Activity of Kaempferol Towards Dengue Virus and Japanese Encephalitis Virus.
    Care C; Sornjai W; Jaratsittisin J; Hitakarun A; Wikan N; Triwitayakorn K; Smith DR
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32164193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An adenosine nucleoside inhibitor of dengue virus.
    Yin Z; Chen YL; Schul W; Wang QY; Gu F; Duraiswamy J; Kondreddi RR; Niyomrattanakit P; Lakshminarayana SB; Goh A; Xu HY; Liu W; Liu B; Lim JY; Ng CY; Qing M; Lim CC; Yip A; Wang G; Chan WL; Tan HP; Lin K; Zhang B; Zou G; Bernard KA; Garrett C; Beltz K; Dong M; Weaver M; He H; Pichota A; Dartois V; Keller TH; Shi PY
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20435-9. PubMed ID: 19918064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
    Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel inhibitor of dengue virus replication that targets the capsid protein.
    Byrd CM; Dai D; Grosenbach DW; Berhanu A; Jones KF; Cardwell KB; Schneider C; Wineinger KA; Page JM; Harver C; Stavale E; Tyavanagimatt S; Stone MA; Bartenschlager R; Scaturro P; Hruby DE; Jordan R
    Antimicrob Agents Chemother; 2013 Jan; 57(1):15-25. PubMed ID: 23070172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.